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http://www.springerplus.com/content/2/1/622RESEARCH Open AccessUse of UPLC-ESI-MS/MS to quantitate free amino
acid concentrations in micro-samples
of mammalian milk
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Although free amino acids (FAA) account for a small fraction of total nitrogen in mammalian milk, they are more
abundant in human milk than in most formulas, and may serve as a readily available source of amino acids for
protein synthesis, as well as fulfill specific physiologic roles. We used reversed phase Ultra Performance Liquid
Chromatography (UPLC) coupled to electrospray ionization tandem mass spectrometry (ESI-MS/MS) technique for
FAA profiling in milks from three species (human, rat and cow) with a simple and rapid sample preparation. The
derivatization procedure chosen, combined with UPLC-ESI-MS/MS allowed the quantitation of 21 FAA using labeled
amino acids (Internal Standards) over a 10 min run time in micro-samples of mammalian milk (50 μL). The low limit
of quantitation was 0.05 pmol/μL for most FAA with good repeatability and reproducibility (mean CV of 5.1%).
Higher levels of total FAA were found in human (3032 μM) and rat milk (3460 μM) than in bovine milk (240 μM),
with wide differences in the abundances of specific FAA between species. This robust analytical method could be
applied to monitor FAA profile in human breast milk, and open the way to individualized adjustment of FAA
content for the nutritional management of infants.
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Due to its many health benefits, breastfeeding is consid-
ered the gold standard for feeding infants in the first
6 months of life (Horta et al. 2007). The composition of
milk therefore has long been the focus of intense scru-
tiny in humans as well as other mammalian species
(Jensen 1995). Among macronutrients, protein is of key
importance since milk protein content largely deter-
mines the initial growth rate of the pups. Protein con-
centration varies by a factor of 10 among mammals,
with the lowest content for humans (10 to 11 g/L)
(Jensen 1995), an intermediate content for cows (34 g/L)
(Lindmark-Mansson et al. 2003) and the highest for ro-
dents (80 to 100 g/L) (Grigor et al. 1986), and marine
mammals (110 to 130 g/L) (Arnould and Boyd 1995).
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reproduction in any medium, provided the orighigher the initial postnatal growth rate (Riek 2008), and
the bound amino acid content of milk protein have long
been documented both in humans (Yamawaki et al. 2005)
and in other species (Lindmark-Mansson et al. 2003).
Besides protein, mammalian milk contains many non-
protein nitrogen compounds including urea, ammonia,
creatine, creatinine, amines, and free amino acids (FAA).
Although, FAA account for only 2% of total nitrogen in
human milk (Carratù et al. 2003), they may serve as a
source of readily available nitrogen, particularly in the
small intestine of preterm infants with limited proteo-
lytic enzymatic activity (Schanler and Garza 1987), and
thus impact early postnatal growth. In addition, besides
their role as building blocks for protein synthesis, several
amino acids have a specific physiologic role, and their
availability during the first few weeks of life may be of
crucial importance. For instance, adequate dietary tau-
rine availability is required for a normal retinal structure
in animals (Imaki et al. 1993), and taurine intake over
the first months of life correlates with developmentalger. This is an open access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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cordingly, most infant formulae have been supplemented
with taurine to match the needs of babies. Other free
amino acids may also be conditionally essential in the
first few weeks of life: in a porcine model, maternal ar-
ginine supplementation was shown to increase sows’
milk arginine concentration, and enhance piglet growth
(Mateo et al. 2008).
FAA have been already analyzed in human (Agostoni
et al. 2000; Atkinson et al. 1980; Chuang et al. 2005;
Pamblanco et al. 1989; Sarwar et al. 1998), cow, and
other mammalian (Grigor et al. 1986; Sarwar et al. 1998;
Wu and Knabe 1994) milks. Yet, to the best of our
knowledge, the full FAA profile has not been reported in
rats although the mother-reared rat pup model has been
the most commonly animal model used in neonatal
nutrition. Allowing the determination of the FAA con-
centrations in rat milk should help nutritionists in
the understanding of physiological effects observed in
breastfed pups.
Multiple analytical methods have been developed for
amino acid quantitation in various biological matrices,
including the combination of different techniques of
chromatography and various detection systems such as
ion exchange chromatography amino acid analyzer
(Chuang et al. 2005, Yamawaki et al. 2005), capillary
electrophoresis-fluorescence (Lin and Liu 2004), LC-UV,
LC-fluorescence (Carratù et al. 2003), GC-MS (Namera
et al. 2002, Kaspar et al. 2008), and LC-MS (Dietzen
et al. 2008). Two approaches have been commonly used:
direct analysis, and precolumn derivatization methods
(Jochum et al. 2006). Although fast and simple, the dir-
ect analysis presented insufficient specificity and sensi-
tivity due to the lack of sufficient separation of amino
acid in complex biological samples. The use of precol-
umn derivatization methods improved the sensitivity of
amino acid detection but considerably lengthened sam-
ple preparation time. Over the last decade, the AccQ.
Tag technology was developed using ultra-high perform-
ance liquid chromatography (UPLC) coupled with mass
spectrometry, and resulted in improved efficiency, sensi-
tivity, and limit of detection, and shortened the time of
analysis of free amino acids, compared with conventional
ion exchange techniques (Armenta et al. 2010). Al-
though this analytical method was applied in various
biological matrices (Armenta et al. 2010; Salazar et al.
2012) it has never been applied to human milk or other
mammalian milks.
The aim of this work was to develop, optimize and val-
idate a micro-assay that would require minimal sample
preparation and run time, and that would be suitable for
minimal amounts of milk. We used reversed phase li-
quid chromatography coupled to electrospray ionization
tandem mass spectrometry (ESI-MS/MS) technique forFAA profiling in milks from three species (human, rat
and cow) with a simple and rapid sample preparation.
The AccQ.Tag derivatization combined with UPLC-ESI-
MS/MS offered gains in selectivity and sensitivity using
multiple reaction monitoring (MRM) and allowed the
quantitation of 21 FAA using labeled amino acid internal
standards over a 10 min run time, and in a small volume
of mammalian milk (50 μL) particularly adapted for ro-
dents. This robust analytical method could be applied to
monitor FAA profile in human breast milk, and open
the way to individualized adjustment of FAA content for
the nutritional management of infants.
Materials and methods
Chemicals and reagents
Amino acid standards were purchased from Waters
(Milford, USA), and L-glutamic acid, L-citrulline, L-glu-
tamine, L-tryptophan, taurine, and L-alanine from Sigma-
Aldrich (Saint-Quentin Fallavier, France). L-[1-13C]alanine,
L-[2-15 N]tyrosine, L-[2-15 N]glutamic acid, L-[2-15 N]cit-
rulline and L-[13C6]arginine, to serve as internal standards
were purchased from Cambridge Isotope Laboratories Inc
(Andover, USA), L-[1-13C]arginine from Masstrace Inc
(Woburn, USA), L-[2-15 N]aspartic acid, L-[2-15 N3
]histidine,, L-[2-
15 N]serine, L-[2-15 N]threonine, L-[2H5]
tryptophan, [15 N]taurine, L-[2-15 N]glutamine, L-[1-13C]
glycine, and L-[2H5]phenylalanine were purchased from
Sigma, L-[2-15 N]leucine from Tracer Technologies, inc
(Waterloo, Canada), and L-[1-13C]valine from Eurisotop
(Saint-Aubin, France). Ultrapure water was obtained from
a Milli-Q purifier (Millipore, Eschborn, Germany), UPLC-
grade solvents, derivation reagents, and UPLC column
were purchased from Waters (Milford, USA), acetonitrile
was from Biosolve (Valkenswaard, Netherlands), hydro-
chloric acid (HCl) from CARLO ERBA (Val de Rueil,
France), and sulfosalicylic acid from Sigma-Aldrich.
Milk samples
Human milk was obtained from the biocollection that
has been established at Nantes University Hospital
(Number DC-2009-982). Samples were kept at -80°C
from collection until analysis. Eighteen samples were ob-
tained after one month of lactation. Cow’s milk was ob-
tained from 4 cows from the same herd by milking them
manually at the end of the lactation period (8 months).
Rat milk was obtained from an animal study conducted
in accordance with the European Communities Council
Directive of November 24th 1986 (86/609/EEC) regard-
ing the care and use of animals for experimental proce-
dures and were approved by the Institut National de la
Recherche Agronomique (INRA, Paris, France). Animal
facility was approved by the French Veterinary Depart-
ment and was registered under the number A44276. The
experimental protocol was registered under the number
Table 1 Gradient elution used for free amino acid
analysis (Armenta et al. 2010), Eluent A was 10%
AccQ•Tag™ Ultra concentrate solvent A in deionized
water and eluent B was 100% AccQ•Tag™ Ultra solvent B




Mobile phase Mobile phase Flow rate
A (%) B (%) (mL/min)
0 99.9 0.1 0.7
0.54 99.9 0.1 0.7
5.74 90.0 10.0 0.7
7.74 78.8 21.2 0.7
8.04 40.4 59.6 0.7
8.64 40.4 59.6 0.7
8.73 99.9 0.1 0.7
10.00 99.9 0.1 0.7
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Grigor et al. (Grigor et al. 1986) at the end of the lacta-
tion (18 days). Briefly, pups were removed from their
dams for 2 hours before milk was collected. Dams were
anesthetized with a mix of isofluran and oxygen, on mats
heated during the manipulation, and received an intra-
peritoneal injection of oxytocin (1 unit of Syntocinon;
Sigma-Tau, Ivry-sur-Seine, France) to stimulate milk
let-down. After twenty minutes, dams were shaved and
disinfected with ethanol, and milk was collected by ap-
plying manual pressure to all nipples, until milk flow
ceased. Around 0.5 mL of milk was obtained from each
animal, and was immediately frozen to -80°C.
Sample preparation
Standard solutions were prepared for each amino acid in
0.1 M HCl, and stored at -20°C until analysis. A mixture
was prepared from 21 natural unlabeled amino acids
mixed at relevant concentrations (depending of FAA
concentration in milk) to create an unlabeled standard
pool solution, and diluted with 0.1 M HCl. A labeled
standard pool solution was prepared with 17 labeled
amino acids mixed under the same conditions and used
as an internal standard. The different points of concen-
tration calibration were prepared by adding increasing
amounts of unlabeled standard pool to the labeled in-
ternal standard pool reaching concentration ranges from
2.5 to 50 μM for tryptophan, the less concentrated FAA
in milk, and from 100 to 2000 μM for glutamic acid, the
more concentrated FAA in milk.
Free amino acids extraction
Because of the small sample volume obtained in small
rodents, the FAA extraction was optimized for use on a
50 μL sample. Prior to extraction, frozen milk samples
were thawed on ice. One hundred microliters of labeled
internal standard pool were added into a 200 μL aliquot of
each milk sample (human and cow milk). One hundred
fifty microliters of ultrapure water and 25 μL of labeled in-
ternal standard pool were added to 50 μL of rat milk.
All samples were mixed and defatted by centrifugation
at 10 000 g for 15 min at 4°C. The upper (lipid) phase
was removed (200 μL), and proteins were precipitated in
the aqueous supernatant by adding 20 μL of a 10%
(wt/v) solution of sulfosalicylic acid (SSA) in water,
followed by centrifugation at 10 000 g for 15 min at 4°C.
The supernatant phase was collected.
AccQ•Tag™ ultra derivatization
FAA were derivatized by adding a mixture of 70 μL of
AccQ•Tag™ Ultra Borate Buffer (Armenta et al. 2010),
10 μL of supernatant and 20 μL of AccQ•Tag™ Ultra
reagent (6-aminoquinolyl-N-hydroxysuccinimidyl carba-
mate), followed by incubation for 10 min at 55°C.LC-MS/MS parameters
UPLC analysis
Liquid chromatographic separation was performed on
an Acquity H-Class® UPLC system (Waters Corporation,
Milford, USA) equipped with a quaternary solvent
manager, an autosampler maintained at 4°C, a Waters
AccQ•TagTM Ultra column (2.1 mm × 10 mm, 1.7 μm
particles) with a pre-filter heated at 55°C, and coupled
with a tandem quadrupole detector. Initial tests were
performed with the gradient recommended in the
AccQ•Tag UltraTM assay kit for amino acids from
Waters developed for UV detection, but the peak
resolutions were not sufficient for MS detection. The
nonlinear separation gradient used was reported by
Armenta et al. (2010), and is detailed in Table 1 with a
mobile phase flow rate of 0.7 mL/min. One microliter of
sample was injected in duplicate into the UPLC system.ESI-MS/MS analysis
UPLC-MS/MS analysis was carried out on a Xevo TQD®
(Waters Corporation, Milford, U.S.A.). We used parame-
ters of detection as detailed by Armenta et al. (2010).
The ESI source was operated at 150°C with a desolvata-
tion temperature of 450°C, a 900 L/h desolvatation gas
flow rate and a capillary voltage set at 3.2 kV. The ex-
tractor voltage was set at 3.0 V, and the radio frequency
voltage at 2.5 V. The cone voltage varied from 27-39 V,
depending on the amino acid investigated. Argon was
used as the collision gas, and collision energies varied
from 19 to 35 eV. Multiple Reaction Monitoring (MRM)
was performed in the positive mode. Integration and
quantitation were performed using the Waters Targe-
tLinksTM software.
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Calibration curves were constructed by plotting the peak
area ratios of unlabeled standard and internal standard
(IS) versus the concentration of each amino acid, and
used to determine the concentrations of each FAA in
milk samples.
Method validation
The method was validated for linearity and limit of
quantitation, recovery, within- and between-sample re-
peatability, and reproducibility. The upper and lower
limits of detection were determined and defined the do-
main of linearity of the method. Recovery (expressed as
percent of added amount) was determined by the ana-
lysis of aliquots of human milk spiked with known
amounts of unlabeled FAA. The between-sample repeat-
ability was established by analyzing 10 supernatants ob-
tained by extraction from the same sample of human
milk. The within-sample repeatability was determined by
repeatedly injecting on the same day the same extract or
the same calibration solution into the instrument. Re-
producibility was evaluated by having the same milk
sample extracted by two different operators, and ana-
lyzed 6 times on different days.
Results
Method performance
The method was optimized and validated for quantifica-
tion of 21 FAA in every milk tested.
FAA extraction optimization
Preliminary experiments were performed to optimize ex-
traction yield and chromatographic profile. Protein pre-
cipitation was tested with methanol and SSA (Agostoni
et al. 2000; Chuang et al. 2005) with graded volumes of
SSA, 20 μL, 100 μL, and 200 μL, and at two different
SSA concentrations (10% and 35%). The best peak pro-
files were observed with 20 μL of 10% SSA. Milk delipi-
dation was also tested and FAA recovery was similar
after milk delipidation. We therefore elected to include
the delipidation and deproteinization steps in the pro-
cedure in order to inject a sample as pure as possible
into the ESI-MS/MS instrument.
Derivatization optimization
In preliminary experiments graded volumes of AccQ•Tag™
Ultra reagent were tested to optimize derivatization. As
the 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate
(AQC) was in large excess, we tested a lower volume of
reagent. Only 10 μL of AccQ•Tag™ Ultra reagent in 80 μL
of borate buffer and 10 μL of standard or supernatant milk
sample were added, and a comparison was made between
three ranges conducted under both conditions (data not
shown). The slopes were similar, as were the coefficientsof determination. Our ability to detect peaks of aminoqui-
nolyl (AMQ) and di-urea aminoquinolyl (di-AMQ) (high
intensity) ensured that reagents were consistently in ex-
cess. For all subsequent derivatization, the protocol there-
fore used 10 μL of AccQ•Tag™ Ultra reagent and 80 μL of
borate buffer for human and cow milk or 60 μL for rat
milk, with resp. 10 μL of supernatant (human/cow milk)
or 30 μL of supernatant (rat milk).
ESI- MS/MS optimization
To optimize the MS/MS parameters and create a MRM
method, each derivatized amino acid was first injected
by direct infusion into the tandem quadrupole mass
spectrometer. In our case, the drift (AQC) largely in ex-
cess of the product derivation (AMQ) was found highly
concentrated compared to the amounts of amino acids
present in sample suggested a strong contamination of
the mass analyzer after direct infusion. Transitions of
the majority of amino acids are reported by Armenta et
al. (2010). For other amino acids like glutamine, lysine
and cystine, the default setting was used (Table 2), by
injecting 25 μM solutions on column. The predominant
ions and retention time were detected by MS Scan. Each
amino acid produced the same daughter ion (m/z = 171),
corresponding to the cleavage of ureide bond of the
AccQ•Tag adduct in each amino acid derivative. The
run time was divided into five segments distributed over
the duration of the liquid chromatographic run (Table 2).
Figure 1 presents the ion chromatogram obtained from
a representative sample of human milk. The dwell time
for each amino acid was optimized to obtain sufficient
data points for accurate quantitation. The MRM transi-
tions, cone voltages, collision energies, and correspond-
ing internal standards are listed in Table 2.
Method validation
A pool of standard solutions containing 21 amino acids
and 17 internal standards was prepared and diluted with
0.1 N HCl to appropriate concentrations. Two replicates
of a diluted solution aliquot were injected into the instru-
ment to determine the limits of quantitation and the dy-
namic range of the method. Results are presented in
Table 3, and an example of calibration curve obtained for
taurine is given in Figure 2. The R2 value of the regression
analysis over the linear range exceeded 0.99 for all FAA.
The LLOQ was 0.05 pmol/μL for most FAA correspond-
ing to a limit of detection (LOD) of 15 fmol/μL.
For all amino acids tested, the recoveries calculated by
adding known amounts of natural amino acids to
aliquots of human milk, exceeded 95%. In milk, regar-
ding within-sample repeatability, the mean coefficients
of variation (CV%) obtained were 1.6%, and ranged be-
tween 0.2% (for taurine) and 4.2% (for arginine). As for
the between-sample repeatability, the mean CV was

















1 L-Histidine 326.21 >171 35 19 1.33 1 1.1 – 2.0 2
2 L-[2-15 N3]Histidine 329.21 > 171 35 19 1.33 1 1.1 – 2.0
3 Taurine 296.11 > 171 32 24 1.76 1 1.1 – 2.0 4
4 [15 N]Taurine 297.11 > 171 32 24 1.76 1 1.1 – 2.0
5 L-Serine 276.11 > 171 27 19 2.12 2 1.9 – 3.4 6
6 L-[2-15 N]Serine 277.11 > 171 27 19 2.12 2 1.9 – 3.4
7 L-Glutamine 317.14 > 171 35 20 2.26 2 1.9 – 3.4 8
8 L-[2-15 N]Glutamine 318.14 > 171 35 20 2.26 2 1.9 – 3.4
9 L-Arginine 345.21 > 171 35 19 2.34 2 1.9 – 3.4 10
10 L-[1-13C]Arginine 347.21 > 171 35 19 2.34 2 1.9 – 3.4
11 Glycine 246.16 > 171 33 20 2.47 2 1.9– 3.4 12
12 L-[1-13C]Glycine 247.16 > 171 33 20 2.47 2 1.9 – 3.4
13 L-Aspartic acid 304.11 > 171 32 24 2.78 2 1.9 – 3.4 14
14 L-[2-15 N]Aspartic Acid 305.11 > 171 32 24 2.78 2 1.9 – 3.4
15 L-Glutamic acid 318.11 > 171 32 24 3.62 3 3.4 – 6.0 16
16 L-[2-15 N]Glutamic Acid 319.11 > 171 32 24 3.62 3 3.4 – 6.0
17 L-Citrulline 346.21 > 171 32 24 3.72 3 3.4 – 6.0 18
18 L-[2-15 N]Citrulline 347.21 > 171 32 24 3.72 3 3.4 – 6.0
19 L-Threonine 291.11 > 171 31 22 4.30 3 3.4 – 6.0 20
20 L-[2-15 N]Thréonine 291.11 > 171 31 22 4.30 3 3.4 – 6.0
21 L-Alanine 260.00 > 171 32 25 4.76 3 3.4 – 6.0 22
22 L-[1-13C]Alanine 261.00 > 171 32 25 4.76 3 3.4 – 6.0
23 L-Proline 286.16 > 171 29 21 5.37 3 3.4 – 6.0 22
24 L-Cystine 291.18 > 171 32 24 6.50 4 6.2 – 7.5 31
25 L-Tyrosine 352.21 > 171 32 24 6.61 4 6.2 – 7.5 26
26 L-[2-15 N]Tyrosine 353.21 > 171 32 24 6.61 4 6.2 – 7.5
27 L-Lysine 487.11 > 171 32 24 6.63 4 6.2 – 7.5 28
28 L-[13C6]Lysine 493.23 > 171 32 24 6.63 4 6.2 – 7.5
29 L-Methionine 320.21 > 171 32 24 6.80 4 6.2 – 7.5 31
30 L-Valine 288.23 > 171 35 24 6.98 4 6.2 – 7.5 31
31 L-[1-13C]Valine 289.23 > 171 35 24 6.98 4 6.2 – 7.5
32 L-Isoleucine 302.20 > 171 39 35 7.85 5 7.5 – 8.5 34
33 L-Leucine 302.20 > 171 39 35 7.94 5 7.5 – 8.5 34
34 L-[2-15 N]Leucine 303.20 > 171 39 35 7.94 5 7.5 – 8.5
35 L-[2H5]Phenylalanine 341.21 > 171 32 24 8.01 5 7.5 – 8.5
36 L-Phenylalanine 336.21 > 171 32 24 8.04 5 7.5 – 8.5 35
37 L-[2H5]Tryptophan 380.23 > 171 32 24 8.10 5 7.5 – 8.5
38 L-Tryptophan 375.23 > 171 32 24 8.13 5 7.5 – 8.5 37
*Note: Before 1.10 min and after 8.50 min the flow state was in waste.
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4.5% (for arginine), except for lysine and cystine (5.6%).
Regarding reproducibility, the mean CV was 5.1%.
All CV obtained for reproducibility are presented in
Table 3.Application to human and mammalian milk analysis
The LLOQ calculated in human milk samples were
within 0.75-3 μM taking into account the dilution factor
corresponding to a LOD within 0.2-0.9 μM. Mean con-
centrations for 21 FAA for human, bovine and rat
Figure 1 Ion chromatogram obtained for FAA in human milk (cumulative).
Table 3 Calibration data, dynamic range and human milk
reproducibility of FAA (n = 6)
Free amino
acid
Linear regression data Dynamic range CV (%)b
r2 pmol/μLa
L-Histidine 0.9998 0.10 – 133.3 2.8
Taurine 0.9993 0.05 – 100 1.8
L-Serine 0.9994 0.05 – 26.7 2.3
L-Glutamine 0.9982 0.05 – 100 8.3
L-Arginine 0.9956 0.1 – 6.7 10.0
Glycine 0.9991 0.05 – 26.7 2.3
L-Aspartic acid 0.9980 0.05 – 26.7 2.9
L-Glutamic acid 0.9986 0.05 – 200 1.6
L-Citrulline 0.9974 0.05 – 5 8.6
L-Threonine 0.9990 0.05 – 26.7 2.8
L-Alanine 0.9953 0.05 – 53.3 2.2
L-Proline 0.9984 0.2 – 53.3 7.1
L-Cystine 0.9948 0.05 – 53.3 15.5
L-Tyrosine 0.9958 0.05 – 26.7 2.7
L-Lysine 0.9954 0.1 – 6.7 8.5
L-Methionine 0.9973 0.05 – 26.7 2.7
L-Valine 0.9973 0.05 – 26.7 2.5
L-Isoleucine 0.9947 0.05 – 13.3 4.4
L-Leucine 0.9968 0.05 – 13.3 2.9
L-Phenylalanine 0.9982 0.05 – 26.7 7.0
L-Tryptophan 0.9986 0.05 – 5 7.5
aassay concentration of AQC amino acid derivatives, 1 μL injected.
bcoefficient variation of reproducibility, calculated on 6 independent milk
samples tested on 2 days with 2 operators.
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total FAA were found in human milk (3032 μM), and rat
milk (3460 μM), compared with bovine milk (240 μM).
Because of the conversion of glutamine to glutamic acid,
the sum of both concentrations was calculated and is
annotated as Glx in the text. Glx was by far the most
abundant FAA (1861 μM) of human milk, accounting
for about 61% of the total FAA, followed by taurine
(311 μM) (10%), and alanine (226 μM) (7.5%). For all an-
alyzed samples of breast milk, the sum of glutamine and
glutamic acid correlates well (R2 = 0.97) with the sum of
FAA (Figure 3). Glx was the most abundant FAA in bo-
vine milk as well (136 μM), accounting for about 56% of
the total FAA, followed by several amino acids at very
similar levels representing only 5-8% of total FAAs (ly-
sine (20 μM), alanine (15 μM), glycine and proline
(13 μM)).The most abundant FAA in rat milk clearly
was alanine (679 μM) (20%), followed by proline
(424 μM) (12%), and Glx (413.5 μM) (12%). The essen-
tial amino acids (EAA) and the amino acids considered
conditionally essential for human newborns (Arg, Ile,
Leu, Lys, Met, Phe, Thr, Trp, Val) had low concentra-
tions in breast milk, compared with non essential amino
acids (EAA/NEAA of 10%), whereas essential amino
acids represented a higher proportion of total amino
acids in rat milk (with an EAA/NEAA ratio of 42%). Sul-
fur amino acids (Tau, cys-cys, Met) represented between
3.9% and 11.7% of total amount of FAA in the milk of
the three species tested.
Discussion
The present work describes the development, optimiza-
tion, and validation of a micro assay for the quantitation
y = 0.8893x + 7.5145
r² = 0.9993
Figure 2 Internal calibration curve for taurine.
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using UPLC-ESI-MS/MS. Whereas FAA have been
quantitated in human and cow milk with numerous ana-
lytical methods in earlier studies, the current report is
first to provide data for rat milk free amino acids. In the
current study, to ensure accurate quantitation of amino
acids in biological samples, all validation steps were car-
ried out in the milk samples, and the matrix effect was
measured by the calculation of recovery for all FAA. The
high recoveries (>95%) obtained in milk are similar to
those achieved using other methods (Agostoni et al.
2000; Carratù et al. 2003). In addition, the limits of
detection (LOD) in human milk (between 0.2 -
0.9 μmol/L) are significantly lower than those (3.3 μmol/L)
reported by Carratù et al. ( 2003), and Agostoni et al.
(2000) using HPLC-fluorescence detection. At the lower
limit of quantitation (LLOQ), the precision was better
than 10% except for cystine.
We observed striking interspecific differences between
mature milks of human, ruminant, and rodent regarding
both total FAA (from 240 to 3460 μM), the nature of the
most abundant FAA, the EAA/NEAA ratio (from 10% to
42%), and the percentage of sulfur amino acids (from 4%
to 11.7%).
The human milk samples obtained from our biocollec-
tion originated from lactating mothers donating their
milk during the first two months of lactation. Taking
into account the inter-individual variations, the FAA
levels observed are very similar to those obtained in
previous studies using a Beckman amino acid analyzer
(Atkinson et al. 1980; Chuang et al. 2005) or HPLC-
Fluorescence (Pamblanco et al. 1989), and higher than
the average 1189 μM reported by Pamblanco et al.
(1989) using HPLC-UV. The method used in our mam-
malian milk analysis yields results similar to those
obtained with other methods such as reversed-phase
HPLC, amino acid analyzer, and ion exchangechromatography amino acid analyzer. Consistent with
previous studies (Atkinson et al. 1980; Chuang et al.
2005; Sarwar et al. 1998), we found Glx, taurine and ala-
nine to be the three most abundant FAA, and the EAA/
NEAA ratio between 11 and 13% concurs with published
values as well (Carratù et al. 2003).
Although the composition of many mammalian milks
has been analyzed (Sarwar et al. 1998), to the best of our
knowledge, the current study is first to report the FAA
concentrations of rat milk. Whereas Glx was the most
abundant amino acid in human and bovine milk, alanine
was the most abundant amino acid in rat milk, followed
by proline and Glx (Figure 4). The higher EAA/NEAA
ratio observed in rat milk (42%) is consistent with the
view that rat pups are born more immature than human
infants and calves, and therefore are more comparable
to human premature neonates with higher nutritional
requirements and faster growth rates.
In cow milk, we found lower total FAA (240 μM) than
reported in the few earlier studies analyzing FAA in
bovine milk (350 - 460 μM (Jensen 1995) to 1061 μM
(Sarwar et al. 1998)). In addition, although two studies
(Lindmark-Mansson et al. 2003; Sarwar et al. 1998)
found Gln, and Tau to be nearly as abundant, we found
Glx was by far the most abundant FAA, with much
lower levels of other amino acids such as Ala, Gly, Lys,
Pro, and Tau in bovine milk. The striking differences ob-
served in free amino acid content and composition be-
tween bovine and human milk raise an important issue:
does the specific free amino acid composition of human
milk provide any health benefit? If so, should infant for-
mulas, which are prepared from bovine milk, be supple-
mented with specific FAA (besides taurine)? These
questions clearly warrant further investigation.
As a matter of fact, although milk FAA can be consid-
ered as micronutrients, several amino acids are sus-
pected to have physiological effects in the infant,
Table 4 FAA in human milk (at 1 month of lactation), cow milk, and rat milk (Values are reported as means, standard
deviation, minimum and maximum)
Free amino
acids μmol/L
Human milk (n = 16) Rat milk (n = 8) Cow milk (n = 4)
Mean SD Min Max Mean SD Min Max Mean SD Min Max
Alanine 225.9 73.4 123.1 385.1 679.0 239.8 261.8 990.9 11.8 10.7 0.8 26.2
Arginine 19.5 12.4 1.5 42.8 53.8 34.0 14.1 119.1 10.7 4.9 3.8 15.4
Aspartic Acid 68.8 36.1 23.2 146.7 225.7 47.7 171.0 320.1 5.4 5.5 0.8 12.3
Citrulline 7.1 3.2 1.9 13.6 42.5 21.4 9.3 68.7 <LLOQ - - -
Cystine 21.0 8.7 11.2 43.0 33.1 21.3 4.2 64.2 <LLOQ - - -
Glx 1,860.7 586.2 926.0 3,040.4 413.5 102.2 212.4 528.0 136.2 64.5 58.9 216.5
Glycine 112.7 37.3 61.4 202.2 133.4 58.8 38.1 195.6 13.0 5.9 4.7 17.6
Histidine 31.4 14.3 12.4 67.5 39.6 19.6 10.8 69.3 2.6 1.6 0.5 4.4
Isoleucine 10.0 6.9 1.0 27.0 26.2 16.0 7.5 53.1 2.0 0.9 0.8 2.7
Leucine 30.0 12.3 12.7 60.6 59.8 33.1 18.9 114.8 2.3 1.3 0.8 3.8
Lysine 33.0 21.6 5.8 84.6 316.0 168.6 45.0 543.5 20.3 12.1 2.2 27.1
Methionine 6.9 5.4 0.8 18.1 81.4 25.0 42.5 118.4 <LLOQ - - -
Phenylalanine 12.9 4.5 5.8 19.8 39.8 20.5 13.5 71.6 <LLOQ - - -
Proline 40.4 15.8 17.6 82.5 424.4 108.5 221.7 588.7 12.8 1.3 10.9 13.9
Serine 97.6 28.8 55.4 143.6 204.2 67.5 73.9 291.1 3.2 2.0 0.8 5.4
Taurine 310.6 142.9 168.3 743.0 181.3 25.6 141.9 220.0 7.0 7.4 0.8 16.5
Threonine 81.5 27.7 45.4 132.0 309.3 122.4 99.3 528.4 3.5 2.0 0.8 5.7
Tryptophan 3.4 1.7 0.8 6.2 31.0 13.8 11.0 55.0 1.5 0.5 0.8 1.9
Tyrosine 15.6 11.0 0.8 35.3 67.4 32.8 21.4 119.8 <LLOQ - - -
Valine 51.5 17.4 27.1 93.6 98.8 45.6 37.6 166.5 4.7 3.1 0.8 7.8
Total (μM) 3,031.6 775.0 1,997.7 4,569.4 3,460.2 1,028.1 1,557.9 4,868.7 240.5 90.8 169.3 367.1
EAA (μM)b 274.6 94.2 177.0 524.0 1 055.6 464.8 300.2 1 826.0 49.0 25.3 11.7 65.1
EAA/Total (%) 9.1 2.2 6.3 12.8 29.2 5.8 19.3 37.5 21.2 13.1 6.5 38.0
NEAA (μM)b 2,757.0 715.8 1,767.2 4,192.2 2,404.6 585.7 1,257.6 3,042.7 191.5 82.1 105.0 302.0
NEAA/Total (%) 90.9 2.2 87.2 93.7 70.8 5.8 62.5 80.7 78.8 13.1 62.0 93.5
EAA/NEAA 0.10 0.03 0.07 0.15 0.42 0.11 0.24 0.60 0.30 0.23 0.07 0.61
Glx/Total (%) 60.6 5.5 46.4 69.3 12.2 1.5 10.2 13.9 55.6 15.4 34.8 71.8
SAA (μM)c 335.0 143.8 181.9 757.6 295.8 60.5 222.8 378.1 8.5 7.4 2.3 18.0
SAA/Total (%) 11.7 5.9 5.8 27.1 9.0 2.4 7.4 14.7 3.9 4.1 0.9 10.0
aGlx: glutamine and glutamic acid.
bEAA: Essential Amino Acids (Sum of His, Arg, Ile, Leu, Lys, Met, Phe, Thr, Trp, Val concentration), NEAA: Non-Essential Amino Acids (Sum of Ala, Asp, Asn, Glu, Gln,
Cys-Cys, Pro, Gly, Ser, Tyr, Cit, Tau concentration) , these EAA were considered as essential for human.
cSAA: Sulfur Amino Acids : taurine. cystine and methionin.
Ferchaud Roucher et al. SpringerPlus 2013, 2:622 Page 8 of 11
http://www.springerplus.com/content/2/1/622especially in the first few months after birth. A few ani-
mal experiments and clinical trials of FAA supplementa-
tion have confirmed these effects. This is particularly the
case for glutamine and alanine, the major FAA present
in the milk of the three species tested. Glutamine is the
most abundant amino acid in the body accounting for
about 60% of FAA in human body, and plays many doc-
umented roles. For instance, glutamine is a major fuel
for the enterocyte, a substrate for purine and pyrimidine
nucleotide synthesis, a regulator of protein synthesis
(Hankard et al. 1996), and a major donor of carbon for
gluconeogenesis (Hankard et al. 1997). Glutamine alsosupports the function of gut associated intestinal muco-
sal system (Wu and Knabe 1994), and gut redox state
(Humbert et al. 2007), and a role of glutamate has re-
cently been proposed for glutamate in the regulation of
food intake (Ventura et al. 2012). Studies performed in
human infants have shown that glutamine is extensively
taken up by splanchnic tissues in the first few days of life
even in preterm infants with a very low birth weight
(Darmaun et al. 1997). Supplementation of infant enteral
feeding with glutamine was shown to decrease infectious
morbidity but not feeding tolerance in very-low birth
weight infants (van den Berg et al. 2005). Alanine, a non
Figure 3 Correlation between the total glutamic acid and glutamine (Glx) concentration and total FAA concentration in human milk
samples (R2 = 0.95).
Figure 4 Box and whisker plots showing the distribution of concentrations of main FAA (Glx, Alanine, Taurine and Proline) in human
and rat milk.
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volved in gluconeogenesis, and in the citric acid cycle. In a
rodent model, alanine was shown to compete for the tau-
rine transport site and to reduce renal cortex taurine con-
tent after its ingestion (Chesney 1988). Taurine and lysine,
the two other prominent FAA in maternal and bovine
milk, respectively, are considered key nutrients for growth
and development. Through its role in bile acid conjuga-
tion, taurine plays a key role in intestinal fat absorption.
Taurine also plays a role in the protection of neurons
against oxidative damage (Huxtable 1992; Wharton et al.
2004) although its beneficial effect on long-term neurode-
velopmental outcome has still to be proven for preterm
infants (Verner et al. 2007). The second most abundant
FAA in milk rat, proline, is a glucogenic amino acid, a pre-
cursor of the polyamines, which play a key role in gut
maturation in human neonates (Plaza-Zamora et al. 2013).
In addition, proline is a precursor of arginine (Tomlinson
et al. 2011), the sole endogenous precursor of nitric oxide,
which plays a critical role in the regulation of intestinal
blood flow. Arginine supplementation was suggested to
decrease risk of necrotizing enterocolitis in preterm infants
(Amin et al. 2002). Wu et al (2011) showed the nutritional
importance of the arginine–proline cycle for the growth
and development of piglet intestine, and supplementation
in arginine increased sow’ milk production and enhanced
the growth of suckling piglets (Mateo et al. 2008).
In conclusion, in this paper, we propose an innovative
method to analyze FAA in mammalian milk. The fast
sample preparation and short run time, and the low
lower limit of detection are definite assets of the
method. We are first to report the free amino acid com-
position of rat milk, and the ability to quantitate free
amino acids in microsamples of milk is a definite advan-
tage to assess milk composition in rodents. Regarding
human milk, the monitoring of free amino acid compos-
ition may be relevant to the nutritional management of
human infants. Many free amino acids indeed are
thought to exert beneficial effects on infant physiology,
but there is a wide range of variation between individuals;
so ensuring specific free amino acids are present in a given
maternal milk, at concentrations high enough to exert a
physiological effect may prove helpful. Moreover, while
many studies have shown that maternal diet can alter the
fatty acid composition in human milk, very little is known
about the potential manipulation of maternal protein and
amino acid diet to alter milk amino acid composition, al-
though a study of Guatemalan mothers suggests the
source of protein (predominantly from plants vs. animal
protein) dietary intake can modulate the free amino acid
content of human milk (Wurtman and Fernstrom 1979).
Exploring such relationship would clearly be warranted, in
view of the increasing interest for research on maternal
milk and its health benefits for human infants.Competing interests
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